RNXT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
RenovoRx Inc (RNXT) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock exhibits bearish technical indicators, lacks significant positive trading trends, and has no immediate catalysts suggesting a strong upward movement. While the company has made progress with its FDA-cleared device and has a positive analyst rating, the financial performance and technical signals do not currently support a buy decision.
The technical indicators are bearish. The MACD is negatively expanding, RSI is neutral at 21.609, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 0.797, with resistance at 0.958. The overall trend suggests weakness in the short term.
RenovoRx's FDA-cleared device, RenovoCath, has been adopted by 12 U.S. cancer centers, reflecting strong market demand. The device has been utilized in over 700 procedures since 2014, leading to increased physician satisfaction and repeat orders. Analyst Justin Walsh initiated coverage with a Buy rating and an $8 price target, citing the device's utility in treating pancreatic cancer.
The stock is in a bearish technical trend, with no significant trading activity from hedge funds or insiders. Financial performance shows a net income loss of -$2.91M in Q3 2025, and EPS dropped by -20% YoY. Congress trading data shows no recent activity, and the stock is expected to decline slightly in the next week.
In Q3 2025, revenue remained flat at $266,000 YoY. Net income improved by 17.85% YoY but remains negative at -$2.91M. EPS dropped by -20% YoY to -0.08. Gross margin remained stable at 80.08%. While there is some improvement in net income, the financials are still weak overall.
Analyst Justin Walsh from JonesResearch initiated coverage with a Buy rating and an $8 price target. The analyst highlights the potential of RenovoCath in treating pancreatic cancer and sees strong commercial potential for the device.
